Swarm Oncology and Cellex Cell Professionals have announced a new partnership with a particular focus on clinical and commercial supply of T cell therapies.  Despite advancements in oncology, more than 82% of patients with advanced metastatic cancer ultimately succumb to their disease.   Current immunotherapies provide only limited survival benefits due to challenges such as T […]